Evidence map›Paper›PMID 30514673›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Effects of sera of rats fed with

Miaoting Yang, Zhijuan Chen, Chunxin Xiao, Waijiao Tang, Beijie Zhou

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Miaoting YangDepartment of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Zhijuan ChenDepartment of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Chunxin XiaoShenzhen Beimei Pharmaceutical Co., Ltd, Shenzhen 518057, China.
Waijiao TangDepartment of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Beijie ZhouDepartment of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.
Southern Medical University · CNZhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effects of sera from rats fed with

methodsFFAs prepared by mixing oleic acid and palmitic acid at the ratio of 2:1. HepG2 cells were treated with the sera from rats fed with low-, moderate-or high-dose HGT (HGT sera) or sera of rats fed with fenofibrate (fenofibrate sera), followed by treatment with 1 mmol/L FFAs for 24 h to induce hepatic steatosis. Oil red O staining was used to observe the distribution of lipid droplets in the cells. The biochemical parameters including triglyceride (TG), lactated hydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured using a commercial kit. The morphological changes of the ER in the cells were observed using transmission electron microscopy. The protein/mRNA expressions of ER stress-related signal molecules including GRP78, PERK, p-PERK, ATF6, ATF4, CASPASE-12, CHOP, XBP-1, PKC, and p-PKC-δ were detected using Western blotting and/or quantitative real-time PCR (qRT-PCR). The changes in the protein expressions of GRP78, p-PERK, CASPASE-12 and CHOP were also detected in cells with transient transfection of PKC-δ siRNA for PKC-δ knockdown.

resultsCompared with the control cells, the cells treated with FFAs showed significantly increased levels of TG, AST, and ALT (

conclusionsHGT serum can effectively prevent FFAs-induced steatosis in HepG2 cells by alleviating ER stress, in which PKC-δ may act as an important target.

Indexed as

SerumAlanine TransaminaseAnimalsAspartate AminotransferasesDisease Models, AnimalDrugs, Chinese HerbalEndoplasmic ReticulumEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressFatty Acids, NonesterifiedFenofibrateHep G2 CellsHumansHypolipidemic AgentsMicroscopy, Electron, TransmissionNon-alcoholic Fatty Liver DiseaseAlanine TransaminaseAspartate AminotransferasesDrugs, Chinese HerbalEndoplasmic Reticulum Chaperone BiPFatty Acids, NonesterifiedFenofibrateHSPA5 protein, humanhugan qingzhiHypolipidemic AgentsRNA, MessengerTabletsTriglyceridesendoplasmic reticulum stressHuganqingzhi tabletsnonalcoholic fatty liver diseaseprotein kinase C-δsteatotic hepatocytes

Identifiers

PMID30514673
PMCPMC6744118
OpenAlexW2992272743

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.